Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 1, 2021

View Archived Issues

Growth factors linked to lysosomes, Parkinson's risk

Adding independent costimulation revs up CARs

Shanghai Longyao receives clinical trial approval in China for LY-007

FDA clears IND for phase I/II study of VX-880 stem cell-derived therapy for type 1 diabetes

Life Science Institute initiates exploratory clinical trial of CL-2020 as treatment of ALS

Janssen's single-shot COVID-19 vaccine shows 85% efficacy in preventing severe disease

Bukwang concludes enrollment of clinical trial of clevudine as treatment of COVID-19

Innovation to initiate phase II study of Brilacidin for the treatment of COVID-19

Nanjing Zhengxiang Pharmaceuticals divulges new MAP4K1 inhibitors

New MAP4K1 inhibitors discovered at Guangdong Newopp Biopharmaceuticals

Medshine Discovery patents multitargeted inhibitors of IRAK-4 and BTK

IGV-001 shows safety and efficacy in phase Ib study in newly diagnosed glioblastoma

PERK inhibition promising for pulmonary arterial hypertension

INCB-001158 plus chemotherapy shows promise for treating advanced biliary tract cancer

Interim data from phase II study of N-803 plus checkpoint inhibitors in NSCLC

DoD funding supports Rigel's phase III trial of fostamatinib in hospitalized COVID-19 patients

Small molecule BC-1618 prolongs Ampk biological activity by targeting Fbxo48

E.U. grants conditional marketing authorization to AstraZeneca COVID-19 vaccine

Amivantamab produces durable responses in patients with exon 20-mutant NSCLC

New galectin-1/galectin-3 inhibitors identified at Galecto Biotech

Allinky Biopharma presents GTPase KRas inhibitors

TGA clears phase III trial of HLX-04-O for wet AMD

Topline results from ENHANCE-IT study of Lypdiso in hypertriglyceridemia

Clover and Dynavax plan H1 initiation of phase II/III trial of adjuvanted COVID-19 vaccine candidate

FDA lifts clinical hold on ACTION-Galactosemia Kids pediatric study of AT-007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...